Scientists hunt for clues to diagnose Parkinson's earlier

NCT ID NCT06501469

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to identify biomarkers—biological clues in the body—that can help distinguish between Parkinson's disease and similar conditions like progressive supranuclear palsy and multiple system atrophy. Researchers will follow people with early-stage parkinsonism and healthy volunteers for at least five years, collecting imaging scans, blood samples, and clinical data. The goal is to improve diagnosis and understanding of these disorders.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to earlier and more accurate diagnosis of Parkinson's disease and related conditions, improving patient care and treatment development.
What could go wrong
This is an observational study, not a treatment trial, so it does not test any therapy. The findings may not lead to immediate clinical changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATYPICAL PARKINSONISM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • HYGEIA Hospital, Parkinson's disease and Movement Disorders Department

    Athens, Athens, 15123, Greece

More trials for these conditions

Other studies related to the condition(s) this trial covers.